Skip to content

TMS-Cobot TS MV

by Axilum Robotics France EUDAMED510(k)

510(k) K182768

Product code QFF

Overview

The TMS-Cobot TS MV is an Electromechanical Arm for a Transcranial Magnetic Stimulation System, designed to assist in precise, automated positioning of the TMS coil during neurological assessments. This device integrates with transcranial magnetic stimulation (TMS) equipment to enhance reproducibility and accuracy of stimulation targeting, particularly in clinical and research settings.

The TMS-Cobot TS MV is supplied as a reusable electromechanical device, intended for use in controlled clinical environments such as neurology departments or research laboratories. It operates in conjunction with TMS systems and is regulated under FDA 510(k) clearance (K182768) and MDR/MDD compliance, with a classification as a Class II medical device. Storage and maintenance requirements are manufacturer-specific, adhering to standard electromechanical device protocols.

Summary written by AI from registry data, 18 Sep 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK182768 Date17 Feb 2019ClearedStatusActive
European UnionCE/MDD EUDAMED Number— Date—StatusActive
European UnionCE/MDR EUDAMED Number— Date—StatusActive

Coverage

2 jurisdictions

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenSwedenLatviaEstoniaUnited States of AmericaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceAustriaHungaryRomaniaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaFranceFranceSloveniaBulgariaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaPortugalSpainSpainItalyUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSpainSpainCroatiaGreeceUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaMaltaCyprusUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Not covered
  • European Union CE/MDD, CE/MDR Active
  • United States FDA 510(k) Active

Recalls: none on record (FDA, checked 6 Oct 2026)

Certificates: none listed in EUDAMED

Specification

EUDAMED · 510(k) · synced 6 Oct 2026

510(k) Number
FDA Product Code
QFF
Device Class
Class II
Regulation
21 CFR Part 882.5805
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Other devices from Axilum Robotics

See all devices from Axilum Robotics →

Questions

  • What clinical settings is the TMS-Cobot TS MV intended for use in, and how does it improve the TMS procedure?

    The TMS-Cobot TS MV is designed for controlled clinical environments such as neurology departments and research laboratories. It assists in precise, automated positioning of the TMS coil during neurological assessments, which enhances reproducibility and accuracy of stimulation targeting—critical for consistent and reliable TMS therapy or research outcomes.

  • Is the TMS-Cobot TS MV a single-use or reusable device, and what maintenance considerations should be noted?

    The TMS-Cobot TS MV is a reusable electromechanical device, meaning it is intended for repeated use in clinical or research settings. Maintenance requirements follow standard protocols for electromechanical devices, though specific storage and upkeep instructions should be followed as outlined by the manufacturer to ensure proper functionality and longevity.

  • How does the TMS-Cobot TS MV integrate with existing TMS systems, and what regulatory pathways does it follow?

    The TMS-Cobot TS MV is specifically designed to integrate with transcranial magnetic stimulation (TMS) equipment, improving targeting precision and reproducibility. Regulatory-wise, it has received FDA 510(k) clearance (K182768) and complies with both the EU Medical Device Directive (MDD) and the Medical Device Regulation (MDR), classifying it as a Class II medical device.

  • What types of neurological assessments or research applications is the TMS-Cobot TS MV particularly suited for?

    While the device itself does not specify clinical indications, its design—enhancing precise coil positioning—makes it particularly useful in neurological assessments and research involving TMS, such as mapping brain function, studying motor cortex excitability, or evaluating treatment responses in conditions like depression, epilepsy, or movement disorders.

Properties & raw data

Show properties, registry sources and raw records

Sources (2)

  • FDA 510(k) K182768 24 fields · synced 6 Oct 2026
  • EUDAMED 1 fields · synced 19 May 2026